Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proactive Treatment With Tacrolimus Ointment in Children With Moderate/Severe Atopic Dermatitis: A Randomized, Multicenter, Open-label Study

NCT01745159 is registered in ClinicalTrials.gov with Astellas Pharma China, Inc. as lead sponsor.

NCT NCT01745159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01745159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proactive Treatment With Tacrolimus Ointment in Children With Moderate/Severe Atopic Dermatitis: A Randomized, Multicenter, Open-label Study
Lead sponsor
Astellas Pharma China, Inc.
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2012
Completion date
November 30, 2013
Enrollment
125 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

moderate/severe atopic dermatitis